Baylor College of Medicine

Baylor led research awarded $31 Million for Resynchronization Therapy in Patients with Heart Failure

A Baylor College of Medicine multi-institution, collaborative study to determine the effectiveness and safety of commonly used pacing treatments for cardiac resynchronization therapy in people with ...
Business Wire

FDA Grants EBR Systems Breakthrough Device Designation Status for the WiSE Cardiac Resynchronization Therapy (CRT) System

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the U.S. Food and Drug Administration (FDA) ...
TCTMD

Medtronic Announces FDA Approval of Consulta® and Syncra™ Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Systems

CRT Innovation is the First to Offer Exclusive OptiVol® Fluid Status Monitoring with Complete Remote Follow-Up for Proactive Heart Failure Management “Atrial arrhythmias are the number one cause of ...
Medscape

ESC Updates Guidance on Cardiac Pacing, Resynchronization Therapy

The European Society of Cardiology (ESC) has released updated guidelines for cardiac pacing and cardiac resynchronization therapy (CRT), which emphasize patient-centered care and shared ...
TCTMD

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe

MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...
Medscape

First Experience With Completely Leadless CRT

Totally leadless cardiac resynchronization therapy (CRT) combining the Micra transcatheter pacing system and a WiSE-CRT system was feasible and associated with significant acute QRS reduction in a ...
News Medical

Cardiac resynchronization therapy improves heart function in cancer survivors

Known as the MADIT-CHIC study, it was the first of its kind to assess whether cardiac resynchronization therapy (CRT) could improve heart function in patients with congestive heart failure and ...
MedPage Today

For Your Patients: Heart Failure Device Therapy

The heart is a finely tuned machine, pumping and squeezing to move blood through the body with a fresh supply of oxygen and nutrients. Electrical activity provides the spark to coordinate and activate ...
Business Wire

Cardiac Resynchronization Therapy (CRT) Market to Reach $8.8 Billion by 2025, with Medtronic, BIOTRONIK, LivaNova, St. Jude Medical & Boston Scientific Dominating - Research ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Cardiac Resynchronization Therapy (CRT) Market (2014-2025)" report to their offering. The global cardiac ...
The American Journal of Managed Care

Patients With Chemotherapy-Induced Cardiomyopathy Show Improvements in LVEF After Cardiac Resynchronization Therapy

With increased recognition of the link between cancer care and heart disease, more studies are evaluating the interconnectedness of cancer survival, chemotherapy, and heart failure (HF) in patients ...
Business Insider

North America Cardiac Rhythm Management Procedures Outlook to 2025 - Pacemaker Implant Procedures, Cardiac Resynchronisation Therapy (CRT) Procedures and Others

New York, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "North America Cardiac Rhythm Management Procedures Outlook to 2025 - Pacemaker Implant Procedures, ...